Chuansheng Xu

550 citations

16 papers · 401 indexed · h-index 10

Co-authors: Miao Wang Liyuan Zhu De‐Pei Liu Huifeng Hao Guihao Chen Xiaogang Sun Hong Chen Qing Wan
Topics: Nitric Oxide and Endothelin Effects (3 papers)Inflammatory mediators and NSAID effects (3 papers)ATP Synthase and ATPases Research (2 papers)
Cited by: Cardiology and Cardiovascular Medicine Cancer Research Biochemistry
Journals: Circulation Nature Communications Journal of the American College of Cardiology
Partner nations: China United States Sweden

In The Last Decade

Chuansheng Xu

16 papers receiving 400 citations

Peers

Countries citing papers authored by Chuansheng Xu

Since Specialization

Citations

This map shows the geographic impact of Chuansheng Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chuansheng Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chuansheng Xu more than expected).

Fields of papers citing papers by Chuansheng Xu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chuansheng Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chuansheng Xu. The network helps show where Chuansheng Xu may publish in the future.

Co-authorship network of co-authors of Chuansheng Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Chuansheng Xu. A scholar is included among the top collaborators of Chuansheng Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chuansheng Xu. Chuansheng Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	Pyroptosis‐Inducing Platinum(IV) Prodrugs via GSDME Pathway for Chemoimmunotherapy and Metastasis Inhibition in Triple‐Negative Breast Cancer 2025 ·Advanced Science ·(unknown),Chuansheng Xu,Yong Zeng,Chunhui Wang,Yan Gao,Jie Ding,Sirui Chen,(unknown),Xin Zhang,Zong‐Wan Mao,Shuo Shi	1
2	A new oxaliplatin(IV) prodrug inducing ferroptosis through a triple-pathway mechanism and activating anti-cancer immunity 2025 ·Science China Chemistry ·(unknown),Nan Huang,Mingyang Li,Xiaoli Zhu,Chunhui Wang,Yue Zhang,Chuansheng Xu,Nailin Yang,(unknown),(unknown),Bing Shen,Shuo Shi	2
3	Engineered Microneedle System Enables the Smart Regulation of Nanodynamic Sterilization and Tissue Regeneration for Wound Management 2025 ·Advanced Science ·Shiyang Lin,Zhongqi Cui,Qingqiong Luo,(unknown),Yue Zhang,(unknown),Yichuan Chen,Chuansheng Xu,Yan Gao,Shasha Zhao,Fenyong Sun,Dandan Shen,Qi Wu,Shuo Shi	2
4	Microsomal prostaglandin E synthase‐1 inhibition prevents adverse cardiac remodelling after myocardial infarction in mice 2023 ·British Journal of Pharmacology ·(unknown),(unknown),Helena Idborg,Liyuan Zhu,Huihui Li,(unknown),(unknown),Ziwei Guo,Lejia Hu,Chuansheng Xu,Hong Chen,Marina Korotkova,Per‐Johan Jakobsson,Miao Wang	6
5	Targeting PDE4B (Phosphodiesterase-4 Subtype B) for Cardioprotection in Acute Myocardial Infarction via Neutrophils and Microcirculation 2022 ·Circulation Research ·Qing Wan,Chuansheng Xu,Liyuan Zhu,(unknown),(unknown),Hong Chen,(unknown),Erli Zhang,Hongyue Wang,Fei Chu,Xuan Ning,(unknown),Jinqing Yuan,Yongjian Wu,Yü Huang,Shengshou Hu,De‐Pei Liu,Miao Wang	41
6	LPA ₂ Contributes to Vascular Endothelium Homeostasis and Cardiac Remodeling After Myocardial Infarction 2022 ·Circulation Research ·Jianqiu Pei,Lin Cai,Fang Wang,Chuansheng Xu,(unknown),Hongwei Guo,Xiaogang Sun,Jerold Chun,Xiangfeng Cong,Weiquan Zhu,Zhe Zheng,(unknown)	44
7	Lysophosphatidic Acid Receptor 3 Suppress Neutrophil Extracellular Traps Production and Thrombosis During Sepsis 2022 ·Frontiers in Immunology ·(unknown),Chuansheng Xu,Jianqiu Pei,(unknown),Rui Peng,Tiewei Li,Junjie Zhang,Xiangfeng Cong,Jerold Chun,Fang Wang,Xi Chen	8
8	Cardiomyocyte-derived small extracellular vesicles can signal eNOS activation in cardiac microvascular endothelial cells to protect against Ischemia/Reperfusion injury 2020 ·Theranostics ·Guihao Chen,Chuansheng Xu,Thomas G. Gillette,Tongyi Huang,Peisen Huang,Qing Li,(unknown),Qinfeng Li,(unknown),Ruijie Tang,(unknown),Yuyan Xiong,Xiaqiu Tian,Jun Xu,Junyan Xu,(unknown),Cong Wei,Chen Jin,Joseph A. Hill,Yuejin Yang	58
9	The cyclic adenosine monophosphate elevating medicine, forskolin, reduces neointimal formation and atherogenesis in mice 2020 ·Journal of Cellular and Molecular Medicine ·Huifeng Hao,Xiaoyan Ma,Hong Chen,Liyuan Zhu,(unknown),Qiaoling Li,Chuansheng Xu,(unknown),(unknown),Miao Wang	13
10	The cyclooxygenase-1/mPGES-1/endothelial prostaglandin EP4 receptor pathway constrains myocardial ischemia-reperfusion injury 2019 ·Nature Communications ·Liyuan Zhu,Chuansheng Xu,(unknown),Huifeng Hao,Qing Wan,Hong Chen,Xu Zhang,Richard Breyer,Yü Huang,Xuetao Cao,De‐Pei Liu,Garret A. FitzGerald,Miao Wang	57
11	INHIBITION OF MIR-128-3P BY TONGXINLUO PROTECTS HUMAN CARDIOMYOCYTES FROM ISCHEMIA/REPERFUSION INJURY VIA UPREGULATION OF P70S6K1/P-P70S6K1 2018 ·Journal of the American College of Cardiology ·Guihao Chen,Chuansheng Xu,Yuejin Yang,Jie Zhang,Qing Li	2
12	A Flow Cytometry-based Assay for Measuring Mitochondrial Membrane Potential in Cardiac Myocytes After Hypoxia/Reoxygenation 2018 ·Journal of Visualized Experiments ·Guihao Chen,Yuejin Yang,Chuansheng Xu,Shuo Gao	22
13	A Flow Cytometry-based Assay for Measuring Mitochondrial Membrane Potential in Cardiac Myocytes After Hypoxia/Reoxygenation 2018 ·Journal of Visualized Experiments ·Guihao Chen,Yuejin Yang,Chuansheng Xu,Shuo Gao	12
14	Protective Role of mPGES-1 (Microsomal Prostaglandin E Synthase-1)–Derived PGE ₂ (Prostaglandin E ₂ ) and the Endothelial EP4 (Prostaglandin E Receptor) in Vascular Responses to Injury 2018 ·Arteriosclerosis Thrombosis and Vascular Biology ·Huifeng Hao,Sheng Hu,Qing Wan,Chuansheng Xu,Hong Chen,Liyuan Zhu,(unknown),(unknown),Richard Breyer,Nailin Li,De‐Pei Liu,Garret A. FitzGerald,Miao Wang	23
15	Inhibition of miR-128-3p by Tongxinluo Protects Human Cardiomyocytes from Ischemia/reperfusion Injury via Upregulation of p70s6k1/p-p70s6k1 2017 ·Frontiers in Pharmacology ·(unknown),Chuansheng Xu,Jie Zhang,Qing Li,Hehe Cui,Xiangdong Li,(unknown),Ruijie Tang,Junyan Xu,Xiaqiu Tian,Peisen Huang,Jun Xu,Chen Jin,Yuejin Yang	35
16	Loss of Endothelial CXCR7 Impairs Vascular Homeostasis and Cardiac Remodeling After Myocardial Infarction 2017 ·Circulation ·Huifeng Hao,Sheng Hu,Hong Chen,Dawei Bu,Liyuan Zhu,Chuansheng Xu,Fei Chu,(unknown),Yue Tang,Xiaogang Sun,Bi‐Sen Ding,De‐Pei Liu,Shengshou Hu,Miao Wang	75

About Chuansheng Xu

Chuansheng Xu is a scholar working on Cardiology and Cardiovascular Medicine, Biochemistry and Pharmacology, having authored 16 papers that have together received 401 indexed citations. Recurring topics across this work include Nitric Oxide and Endothelin Effects (3 papers), Inflammatory mediators and NSAID effects (3 papers) and ATP Synthase and ATPases Research (2 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (126 citations), Cancer Research (76 citations) and Biochemistry (33 citations). Chuansheng Xu has collaborated with scholars based in China, United States and Sweden. Frequent co-authors include Miao Wang, Liyuan Zhu, De‐Pei Liu, Huifeng Hao, Guihao Chen, Xiaogang Sun, Hong Chen, Qing Wan, Shengshou Hu and Fei Chu. Their work appears in journals such as Circulation, Nature Communications and Journal of the American College of Cardiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact